Adult Prevention of VTE: Orthopaedic & abdominal surgery
2.5 mg SC once daily for 5-9 days, administered 6 hr following surgical closure provided haemostasis has been established. Medical patient at risk of thromboembolic complications
2.5 mg SC once daily for 6-14 days. Unstable angina/non-ST segment elevation MI
2.5 mg SC initiated as soon as possible following diagnosis & continued for up to 8 days or until hospital discharge. ST segment elevation MI
2.5 mg once daily w/ 1st dose administered IV & subsequent doses administered SC. Initiate treatment as soon as possible following diagnosis & continued for up to 8 days or until hospital discharge. DVT & PE >100 kg
10 mg SC once daily, 50-100 kg
7.5 mg SC once daily, <50 kg
5 mg SC once daily. Continue treatment for at least 5 days & until adequate oral anticoagulation is established.